Trial intelligence / Profile preview

Compound Cortex Moutan & Leech capsules plus aspirin for prethrombotic state in hypertension with or without type 2 diabetes

ChiCTR-OCH-12002780Phase 4Completed

Sponsor
Geriatric Vasculocardiology Department, The First Affiliated Hospital of Henan University of Chinese Medicine
Start
Aug 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of aspirin in hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Geriatric Vasculocardiology Department, The First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Coagulation panel, Platelet aggregation function and 1 more. Started Aug 2012; status: completed.

02

Drugs

aspirin
03

Conditions

hypertension (HTN)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR-OCH-12002780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OCH-12002780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call